世界のアミフォスチン市場:成長動向・競争分析2020-2026

【英語タイトル】Global Amifostine Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP00071)・商品コード:QYR20AP00071
・発行会社(調査会社):QYResearch
・発行日:2020年3月20日(※2024年版があります。お問い合わせください)
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、アミフォスチンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、アミフォスチンのグローバル市場動向、メーカー別競争状況、種類別市場規模(400mg /用量、500mg /用量)、用途別市場規模(頭頸部がんアジュバント療法、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・アミフォスチンの種類別市場2015-2026:400mg /用量、500mg /用量
・アミフォスチンの用途別市場2015-2026:頭頸部がんアジュバント療法、その他
・アミフォスチンの北米市場分析
・アミフォスチンのアジア市場分析
・アミフォスチンの中南米市場分析
・アミフォスチンの中東・アフリカ市場分析
・関連企業情報:Clinigen、Sun Pharmaceutical、Taj Pharmaceuticals、Merro Pharmaceutical、Luye Pharma、Mingren Pharma
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.

Consumption of amifostine mainly concentrates in North America. In 2016, the region consumed 780 K Unit, holding about 52% market share globally. The follower is Asia-Pacific, with about 41% consumption share.

The market is relatively concentrated and there are just a few suppliers in the market, such as Clinigen , Sun Pharmaceutical, Merro Pharmaceutical and so on. Clinigen acquired the business from AstraZeneca in the year of 2014 and signed an agreement with Cumberland in the year of 2016. Under the agreement, Cumberland acquired the exclusive rights to commercialize Ethyol in the United States. Merro Pharmaceutical own the largest sales share in China.

Amifostine shows good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment.
In 2019, the global Amifostine market size was US$ 50 million and is forecast to US$ 59 million in 2026, growing at a CAGR of 2.2% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Amifostine.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Amifostine market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Amifostine market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Amifostine market. Readers of the report can become informed about current and future trends of the global Amifostine market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Amifostine markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Amifostine market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Amifostine market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Amifostine market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Amifostine market is segmented into
400mg/Dose
500mg/Dose

Market Segment by Application, the Amifostine market is segmented into
Head and Neck Cancer Adjuvant Therapy
Others

This report includes the following manufacturers; we can also add the other companies as you want.
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma

The study objectives are:
To analyze and research the global Amifostine status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Amifostine manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Amifostine are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Amifostine Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Amifostine Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 400mg/Dose
1.3.3 500mg/Dose
1.4 Market Segment by Application
1.4.1 Global Amifostine Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Head and Neck Cancer Adjuvant Therapy
1.4.3 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Amifostine Revenue (2015-2026)
2.1.1 Global Amifostine Revenue (2015-2026)
2.1.2 Global Amifostine Sales (2015-2026)
2.2 Amifostine Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Amifostine Sales by Regions (2015-2020)
2.2.2 Global Amifostine Revenue by Regions (2015-2020)
2.3 Global Top Amifostine Regions (Countries) Ranking by Market Size
2.4 Amifostine Industry Trends
2.4.1 Amifostine Market Top Trends
2.4.2 Market Drivers
2.4.3 Amifostine Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Amifostine Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Amifostine Manufacturers by Sales (2015-2020)
3.1.1 Global Amifostine Sales by Manufacturers (2015-2020)
3.1.2 Global Amifostine Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Amifostine Sales in 2019
3.2 Global Top Manufacturers Amifostine by Revenue
3.2.1 Global Amifostine Revenue by Manufacturers (2015-2020)
3.2.2 Global Amifostine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Amifostine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amifostine as of 2019)
3.4 Global Amifostine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Amifostine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Amifostine Market
3.7 Key Manufacturers Amifostine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Amifostine Historic Market Review by Type (2015-2020)
4.1.2 Global Amifostine Sales Market Share by Type (2015-2020)
4.1.3 Global Amifostine Revenue Market Share by Type (2015-2020)
4.1.4 Amifostine Price by Type (2015-2020)
4.1 Global Amifostine Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Amifostine Sales Forecast by Type (2021-2026)
4.2.3 Global Amifostine Revenue Forecast by Type (2021-2026)
4.2.4 Amifostine Price Forecast by Type (2021-2026)

5 Global Amifostine Market Size by Application
5.1 Global Amifostine Historic Market Review by Application (2015-2020)
5.1.2 Global Amifostine Sales Market Share by Application (2015-2020)
5.1.3 Global Amifostine Revenue Market Share by Application (2015-2020)
5.1.4 Amifostine Price by Application (2015-2020)
5.2 Global Amifostine Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Amifostine Sales Forecast by Application (2021-2026)
5.2.3 Global Amifostine Revenue Forecast by Application (2021-2026)
5.2.4 Amifostine Price Forecast by Application (2021-2026)

6 North America
6.1 North America Amifostine Breakdown Data by Company
6.2 North America Amifostine Breakdown Data by Type
6.3 North America Amifostine Breakdown Data by Application
6.4 North America Amifostine Breakdown Data by Countries
6.4.1 North America Amifostine Sales by Countries
6.4.2 North America Amifostine Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Amifostine Breakdown Data by Company
7.2 Europe Amifostine Breakdown Data by Type
7.3 Europe Amifostine Breakdown Data by Application
7.4 Europe Amifostine Breakdown Data by Countries
7.4.1 Europe Amifostine Sales by Countries
7.4.2 Europe Amifostine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Amifostine Breakdown Data by Company
8.2 Asia Pacific Amifostine Breakdown Data by Type
8.3 Asia Pacific Amifostine Breakdown Data by Application
8.4 Asia Pacific Amifostine Breakdown Data by Regions
8.4.1 Asia Pacific Amifostine Sales by Regions
8.4.2 Asia Pacific Amifostine Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Amifostine Breakdown Data by Company
9.2 Latin America Amifostine Breakdown Data by Type
9.3 Latin America Amifostine Breakdown Data by Application
9.4 Latin America Amifostine Breakdown Data by Countries
9.4.1 Latin America Amifostine Sales by Countries
9.4.2 Latin America Amifostine Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Amifostine Breakdown Data by Type
10.2 Middle East and Africa Amifostine Breakdown Data by Application
10.3 Middle East and Africa Amifostine Breakdown Data by Countries
10.3.1 Middle East and Africa Amifostine Sales by Countries
10.3.2 Middle East and Africa Amifostine Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Clinigen
11.1.1 Clinigen Corporation Information
11.1.2 Clinigen Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Clinigen Amifostine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Clinigen Amifostine Products and Services
11.1.5 Clinigen SWOT Analysis
11.1.6 Clinigen Recent Developments
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Corporation Information
11.2.2 Sun Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Sun Pharmaceutical Amifostine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Sun Pharmaceutical Amifostine Products and Services
11.2.5 Sun Pharmaceutical SWOT Analysis
11.2.6 Sun Pharmaceutical Recent Developments
11.3 Taj Pharmaceuticals
11.3.1 Taj Pharmaceuticals Corporation Information
11.3.2 Taj Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Taj Pharmaceuticals Amifostine Products and Services
11.3.5 Taj Pharmaceuticals SWOT Analysis
11.3.6 Taj Pharmaceuticals Recent Developments
11.4 Merro Pharmaceutical
11.4.1 Merro Pharmaceutical Corporation Information
11.4.2 Merro Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Merro Pharmaceutical Amifostine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Merro Pharmaceutical Amifostine Products and Services
11.4.5 Merro Pharmaceutical SWOT Analysis
11.4.6 Merro Pharmaceutical Recent Developments
11.5 Luye Pharma
11.5.1 Luye Pharma Corporation Information
11.5.2 Luye Pharma Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Luye Pharma Amifostine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Luye Pharma Amifostine Products and Services
11.5.5 Luye Pharma SWOT Analysis
11.5.6 Luye Pharma Recent Developments
11.6 Mingren Pharma
11.6.1 Mingren Pharma Corporation Information
11.6.2 Mingren Pharma Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Mingren Pharma Amifostine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Mingren Pharma Amifostine Products and Services
11.6.5 Mingren Pharma SWOT Analysis
11.6.6 Mingren Pharma Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Amifostine Sales Channels
12.2.2 Amifostine Distributors
12.3 Amifostine Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Amifostine Sales Forecast (2021-2026)
13.1.1 Global Amifostine Sales Forecast by Regions (2021-2026)
13.1.2 Global Amifostine Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Amifostine Sales Forecast (2021-2026)
13.2.2 North America Amifostine Revenue Forecast (2021-2026)
13.2.3 North America Amifostine Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Amifostine Sales Forecast (2021-2026)
13.3.2 Europe Amifostine Revenue Forecast (2021-2026)
13.3.3 Europe Amifostine Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Amifostine Sales Forecast (2021-2026)
13.4.2 Asia Pacific Amifostine Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Amifostine Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Amifostine Sales Forecast (2021-2026)
13.5.2 Latin America Amifostine Revenue Forecast (2021-2026)
13.5.3 Latin America Amifostine Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Amifostine Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Amifostine Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Amifostine Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Amifostine Key Market Segments
Table 2. Ranking of Global Top Amifostine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Amifostine Market Size Growth Rate by Type 2021-2026 (MT) & (Million US$)
Table 4. Major Manufacturers of 400mg/Dose
Table 5. Major Manufacturers of 500mg/Dose
Table 6. Global Amifostine Market Share by Application 2019-2025 (MT)
Table 7. Global Amifostine Market Size by Regions 2015-2020 (MT) & (Million US$)
Table 8. Global Amifostine Sales by Regions 2015-2020 (MT)
Table 9. Global Amifostine Sales Market Share by Regions 2015-2020
Table 10. Global Amifostine Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Amifostine Revenue Market Share by Regions 2015-2020
Table 12. Top Amifostine Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Amifostine Key Drivers: Impact Analysis (2021-2026)
Table 15. Amifostine Key Challenges
Table 16. Main Points Interviewed from Key Amifostine Players: Views for Future
Table 17. Global Amifostine Sales by Manufacturers (2015-2020) (MT)
Table 18. Global Amifostine Sales Share by Manufacturers (2015-2020)
Table 19. Amifostine Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Amifostine Revenue Share by Manufacturers (2015-2020)
Table 21. Global Amifostine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amifostine as of 2019)
Table 23. Key Manufacturers Amifostine Average Selling Price (ASP) (2015-2020) (USD/Kg)
Table 24. Key Manufacturers Amifostine Plants/Factories Distribution
Table 25. Key Manufacturers Amifostine Area Served
Table 26. Date of Key Manufacturers Enter into Amifostine Market
Table 27. Key Manufacturers Amifostine Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global 400mg/Dose Sales and Revenue (2015-2020) (MT) & (Million US$)
Table 30. Global 500mg/Dose Sales and Revenue (2015-2020) (MT) & (Million US$)
Table 31. Global Amifostine Sales (MT) by Type (2015-2020)
Table 32. Global Amifostine Sales Share by Type (2015-2020)
Table 33. Global Amifostine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Amifostine Price (MT) by Type (2015-2020)
Table 35. Global Amifostine Sales (MT) by Type (2021-2026)
Table 36. Global Amifostine Sales Share by Type (2021-2026)
Table 37. Global Amifostine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Amifostine Revenue Share by Type (2021-2026)
Table 39. Global Amifostine Price (MT) by Type (2021-2026)
Table 40. Global Amifostine Sales (MT) by Application (2015-2020)
Table 41. Global Amifostine Sales Share by Application (2015-2020)
Table 42. Global Amifostine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Amifostine Price by Application 2015-2020 (USD/Kg)
Table 44. Global Amifostine Sales by Application (2015-2020) (MT)
Table 45. Global Amifostine Sales Share by Application (2015-2020)
Table 46. Global Amifostine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Amifostine Revenue Share by Application (2021-2026)
Table 48. Global Amifostine Price (MT) by Application (2021-2026)
Table 49. North America Amifostine Sales by Company (2015-2020) (MT)
Table 50. North America Amifostine Sales Market Share by Company (2015-2020)
Table 51. North America Amifostine Sales by Type (2015-2020) (MT)
Table 52. North America Amifostine Sales Market Share by Type (2015-2020)
Table 53. North America Amifostine Sales by Application (2015-2020) (MT)
Table 54. North America Amifostine Sales Market Share by Application (2015-2020)
Table 55. North America Amifostine Sales by Countries (2015-2020) (MT)
Table 56. North America Amifostine Sales Market Share by Countries (2015-2020)
Table 57. North America Amifostine Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Amifostine Revenue Market Share by Countries (2015-2020)
Table 59. Europe Amifostine Sales by Company (2015-2020) (MT)
Table 60. Europe Amifostine Sales Market Share by Company (2015-2020)
Table 61. Europe Amifostine Sales by Type (2015-2020) (MT)
Table 62. Europe Amifostine Sales Market Share by Type (2015-2020)
Table 63. Europe Amifostine Sales by Application (2015-2020) (MT)
Table 64. Europe Amifostine Sales Market Share by Application (2015-2020)
Table 65. Europe Amifostine Sales by Countries (2015-2020) (MT)
Table 66. Europe Amifostine Sales Market Share by Countries (2015-2020)
Table 67. Europe Amifostine Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Amifostine Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Amifostine Sales by Regions (2015-2020) (MT)
Table 70. Asia Pacific Amifostine Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Amifostine Sales by Type (2015-2020) (MT)
Table 72. Asia Pacific Amifostine Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Amifostine Sales by Application (2015-2020) (MT)
Table 74. Asia Pacific Amifostine Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Amifostine Sales by Countries (2015-2020) (MT)
Table 76. Asia Pacific Amifostine Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Amifostine Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Amifostine Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Amifostine Sales by Company (2015-2020) (MT)
Table 80. Latin America Amifostine Sales Market Share by Company (2015-2020)
Table 81. Latin America Amifostine Sales by Type (2015-2020) (MT)
Table 82. Latin America Amifostine Sales Market Share by Type (2015-2020)
Table 83. Latin America Amifostine Sales by Application (2015-2020) (MT)
Table 84. Latin America Amifostine Sales Market Share by Application (2015-2020)
Table 85. Latin America Amifostine Sales by Countries (2015-2020) (MT)
Table 86. Latin America Amifostine Sales Market Share by Countries (2015-2020)
Table 87. Latin America Amifostine Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Amifostine Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Amifostine Sales by Type (2015-2020) (MT)
Table 90. Middle East and Africa Amifostine Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Amifostine Sales by Application (2015-2020) (MT)
Table 92. Middle East and Africa Amifostine Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Amifostine Sales by Countries (2015-2020) (MT)
Table 94. Middle East and Africa Amifostine Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Amifostine Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Amifostine Revenue Market Share by Countries (2015-2020)
Table 97. Clinigen Company Details
Table 98. Clinigen Description and Business Overview
Table 99. Clinigen Amifostine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 100. Clinigen Amifostine Sales Growth Rate (2015-2020)
Table 101. Clinigen Amifostine Sales Market Share in Global Market
Table 102. Clinigen Recent Development
Table 103. Sun Pharmaceutical Company Details
Table 104. Sun Pharmaceutical Description and Business Overview
Table 105. Sun Pharmaceutical Amifostine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 106. Sun Pharmaceutical Amifostine Sales Growth Rate (2015-2020)
Table 107. Sun Pharmaceutical Amifostine Sales Market Share in Global Market
Table 108. Sun Pharmaceutical Recent Development
Table 109. Taj Pharmaceuticals Company Details
Table 110. Taj Pharmaceuticals Description and Business Overview
Table 111. Taj Pharmaceuticals Amifostine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Taj Pharmaceuticals Amifostine Sales Growth Rate (2015-2020)
Table 113. Taj Pharmaceuticals Amifostine Sales Market Share in Global Market
Table 114. Taj Pharmaceuticals Recent Development
Table 115. Merro Pharmaceutical Company Details
Table 116. Merro Pharmaceutical Description and Business Overview
Table 117. Merro Pharmaceutical Amifostine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 118. Merro Pharmaceutical Amifostine Sales Growth Rate (2015-2020)
Table 119. Merro Pharmaceutical Amifostine Sales Market Share in Global Market
Table 120. Merro Pharmaceutical Recent Development
Table 121. Luye Pharma Company Details
Table 122. Luye Pharma Description and Business Overview
Table 123. Luye Pharma Amifostine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 124. Luye Pharma Amifostine Sales Growth Rate (2015-2020)
Table 125. Luye Pharma Amifostine Sales Market Share in Global Market
Table 126. Luye Pharma Recent Development
Table 127. Mingren Pharma Company Details
Table 128. Mingren Pharma Description and Business Overview
Table 129. Mingren Pharma Amifostine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 130. Mingren Pharma Amifostine Sales Growth Rate (2015-2020)
Table 131. Mingren Pharma Amifostine Sales Market Share in Global Market
Table 132. Mingren Pharma Recent Development
Table 133. Amifostine Distributors List
Table 134. Amifostine Customers List
Table 135. Global Amifostine Sales Forecast 2021-2026 (MT) & (Million US$)
Table 136. Global Amifostine Sales Forecast by Type 2021-2026 (MT)
Table 137. Global Amifostine Sales Forecast by Application 2021-2026 (MT)
Table 138. Global Amifostine Sales Forecast by Regions 2021-2026 (MT)
Table 139. Global Amifostine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 140. North America Amifostine Sales Forecast by Countries 2021-2026 (MT)
Table 141. North America Amifostine Revenue Forecast by Countries 2021-2026
Table 142. Europe Amifostine Sales Forecast by Countries 2021-2026 (MT)
Table 143. Europe Amifostine Revenue Market Share Forecast by Countries 2021-2026
Table 144. Asia Pacific Amifostine Sales Forecast by Regions 2021-2026 (MT)
Table 145. Asia Pacific Amifostine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 146. Latin America Amifostine Sales Forecast by Countries 2021-2026 (MT)
Table 147. Latin America Amifostine Revenue Forecast by Countries 2021-2026 (Million US$)
Table 148. Middle East and Africa Amifostine Sales Forecast by Regions 2021-2026 (MT)
Table 149. Middle East and Africa Amifostine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Amifostine Product Picture
Figure 2. Global Amifostine Sales Market Shar by Type 2015-2026
Figure 3. 400mg/Dose Figures
Figure 4. 500mg/Dose Figures
Figure 5. Global Amifostine Sales Market Share by Application in 2019 & 2026
Figure 6. Head and Neck Cancer Adjuvant Therapy Use Case
Figure 7. Others Use Case
Figure 8. Amifostine Report Years Considered
Figure 9. Global Amifostine Market Size 2015-2026 (Million US$)
Figure 10. Global Amifostine Sales 2015-2020 (MT)
Figure 11. Global Amifostine Market Size Market Share by Regions 2015-2020
Figure 12. Global Amifostine Sales Market Share by Regions in 2019
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Amifostine Sales Share by Manufacturers in 2019
Figure 15. The 5 and 10 Largest Manufacturers in the World: Market Share by Amifostine Sales in 2019
Figure 16. Amifostine Value Share by Manufacturers in 2019
Figure 17. Amifostine Revenue Share by Manufacturers In 2019
Figure 18. Amifostine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Amifostine Revenue Share by Type (2015-2020)
Figure 20. Global Amifostine Revenue Growth Rate by Type in 2015 & 2019
Figure 21. Global Amifostine Market Share by Price Range (2015-2020)
Figure 22. Global Amifostine Revenue Share by Application (2015-2020)
Figure 23. Global Amifostine Revenue Growth Rate by Application in 2015 & 2019
Figure 24. North America Amifostine Revenue Growth Rate 2015-2020 (Million US$)
Figure 25. U.S. Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 26. Canada Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 27. Europe Amifostine Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. Germany Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 29. France Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 30. U.K. Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 31. Italy Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 32. Russia Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 33. Asia Pacific Amifostine Revenue Growth Rate 2015-2020 (Million US$)
Figure 34. China Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 35. Japan Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 36. South Korea Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 37. India Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 38. Australia Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 39. Taiwan Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 40. Indonesia Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 41. Thailand Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 42. Malaysia Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 43. Philippines Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 44. Vietnam Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 45. Latin America Amifostine Revenue Growth Rate 2015-2020 (Million US$)
Figure 46. Mexico Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 47. Brazil Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 48. Argentina Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 49. Middle East and Africa Amifostine Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Turkey Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 51. Saudi Arabia Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 52. U.A.E Amifostine Sales Growth Rate (2015-2020) (MT)
Figure 53. Clinigen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Taj Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Merro Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Luye Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Mingren Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Amifostine Value Chain
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. North America Amifostine Sales Growth Rate Forecast (2021-2026) (MT)
Figure 63. North America Amifostine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 64. Europe Amifostine Sales Growth Rate Forecast (2021-2026) (MT)
Figure 65. Europe Amifostine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 66. Asia Pacific Amifostine Sales Growth Rate Forecast (2021-2026) (MT)
Figure 67. Asia Pacific Amifostine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 68. Latin America Amifostine Sales Growth Rate Forecast (2021-2026) (MT)
Figure 69. Latin America Amifostine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 70. Middle East and Africa Amifostine Sales Growth Rate Forecast (2021-2026) (MT)
Figure 71. Middle East and Africa Amifostine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed


【掲載企業】

Clinigen、Sun Pharmaceutical、Taj Pharmaceuticals、Merro Pharmaceutical、Luye Pharma、Mingren Pharma

★調査レポート[世界のアミフォスチン市場:成長動向・競争分析2020-2026] (コード:QYR20AP00071)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアミフォスチン市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆